These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3891310)

  • 41. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
    Mordarski M; Chylińska B; Urbański T
    Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of mechanisms of increasing serum RNase].
    Fujimori C; Yamagishi H; Mizukuro T; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):792-8. PubMed ID: 6881998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Enzyme therapy of neoplasms].
    Berezov TT
    Vestn Akad Med Nauk SSSR; 1971; 26(11):35-46. PubMed ID: 4330950
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition by pancreatic ribonuclease of experimental tumour metastasizing in mice.
    Graffi A; Arnold W
    Acta Biol Med Ger; 1973 May; 30(5):K15-8. PubMed ID: 4733624
    [No Abstract]   [Full Text] [Related]  

  • 45. The swapping of terminal arms in ribonucleases: comparison of the solution structure of monomeric bovine seminal and pancreatic ribonucleases.
    Avitabile F; Alfano C; Spadaccini R; Crescenzi O; D'Ursi AM; D'Alessio G; Tancredi T; Picone D
    Biochemistry; 2003 Jul; 42(29):8704-11. PubMed ID: 12873130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the anti-tumor action of N,N'-malonyl-bis-ethyleneimine].
    Anisimov VN
    Vopr Onkol; 1967; 13(2):91-2. PubMed ID: 4971007
    [No Abstract]   [Full Text] [Related]  

  • 47. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 48. [Possibility of elimination of depression of the defense mechanisms of the body caused by antineoplastic antibiotics].
    Mazaeva VG
    Antibiotiki; 1970 May; 15(5):447-9. PubMed ID: 4193822
    [No Abstract]   [Full Text] [Related]  

  • 49. [New models of experimental chemotherapy of tumors].
    Treshchalina EM; Andronova NV; Kobliakov VA; Raĭkhlin NT
    Vopr Onkol; 2001; 47(6):701-5. PubMed ID: 11826492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 51. Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.
    Soucek J; Poucková P; Zadinová M; Hlousková D; Plocová D; Strohalm J; Hrkal Z; Oleár T; Ulbrich K
    Neoplasma; 2001; 48(2):127-32. PubMed ID: 11478693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In vitro and in vivo studies of RNAse of Bacillus intermedius].
    Kurinenko BM; Sergeeva EV; Sobchuk LI; Bulgakova RSh; Khaĭbullina SA
    Antibiot Khimioter; 1989 Apr; 34(4):266-70. PubMed ID: 2751384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The antitumor properties of 3,5-diglycoside-cyanidine].
    Kabiev OK; Vermenichev SM
    Vopr Onkol; 1970; 16(8):60-2. PubMed ID: 5537238
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 55. Some biological actions of PEG-conjugated RNase A oligomers.
    Pouckova P; Skvor J; Gotte G; Vottariello F; Slavik JT; Matousek J; Laurents DV; Libonati M; Soucek J
    Neoplasma; 2006; 53(1):79-85. PubMed ID: 16416018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural and engineered ribonucleases as potential cancer therapeutics.
    Arnold U; Ulbrich-Hofmann R
    Biotechnol Lett; 2006 Oct; 28(20):1615-22. PubMed ID: 16902846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.
    Beck AK; Pass HI; Carbone M; Yang H
    Future Oncol; 2008 Jun; 4(3):341-9. PubMed ID: 18518759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of the antineoplastic and immunoadjuvant activity of acrylic acid (co)polymers].
    Korosteleva TA; Movsesian KS; Nesterova VI; Saprin AN; Meĭia NV
    Eksp Onkol; 1986; 8(4):59-61. PubMed ID: 3757886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of Bacillus natto. II. Formation of cytolytic substances on Ehrlich ascites carcinoma in Bacillus natto KMD 1126.
    Kameda Y; Sagai H; Yamada T; Kanatomo S; Matsui K
    Chem Pharm Bull (Tokyo); 1971 Dec; 19(12):2572-8. PubMed ID: 5145920
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental study of the antineoplastic effect of the preparations 141 and 142 of the diethylenimide alkoxybenzylpyrimidilaminophosphoric acid group and the possibility of their use in combination with radiotherapy].
    Movsesian MA; Garibdzhanian BT; Barkhudarian LKh; Arutiunian DE; Stepanian GM
    Zh Eksp Klin Med; 1977; 17(1):6-10. PubMed ID: 888614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.